According to the company, an application for sales approval will be submitted shortly and the sales of the product will begin at the end of the second quarter in 2009.
Bengt Agerup, president and CEO of Q-Med, said: “There is a large appetite for new things in China and great respect for products from the West. We are therefore very pleased about this registration approval, which means that Restylane will be the first hyaluronic acid product intended for the cosmetic market in China.”